The Impact of Downstream Coronary Stenosis on Fractional Flow Reserve Assessment of Intermediate Left Main Coronary Artery Disease Human Validation by Fearon, William F. et al.
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 8 , N O . 3 , 2 0 1 5
ª 2 0 1 5 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 1 9 3 6 - 8 7 9 8 / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . h t t p : / / d x . d o i . o r g / 1 0 . 1 0 1 6 / j . j c i n . 2 0 1 4 . 0 9 . 0 2 7The Impact of Downstream Coronary
Stenosis on Fractional Flow Reserve
Assessment of Intermediate
Left Main Coronary Artery Disease
Human ValidationWilliam F. Fearon, MD,* Andy S. Yong, MBBS, PHD,* Guy Lenders, MD,y Gabor G. Toth, MD,z Catherine Dao, MD,*
David V. Daniels, MD,* Nico H.J. Pijls, MD, PHD,y Bernard De Bruyne, MD, PHDzABSTRACTFro
Ein
fro
St.
MaOBJECTIVES The aim of this study was to determine the impact of downstream coronary stenosis in the left anterior
descending coronary artery (LAD) or left circumﬂex coronary artery (LCx) on the assessment of fractional ﬂow reserve
(FFR) across an intermediate left main coronary artery (LMCA) stenosis in humans with the pressure wire positioned in the
nondiseased downstream vessel.
BACKGROUND Accurate assessment of intermediate LMCA disease is critical for guiding decisions regarding revas-
cularization. In theory, FFR across an intermediate LMCA stenosis will be affected by downstream disease, even if the
pressure wire is positioned in the nondiseased downstream vessel.
METHODS After percutaneous coronary intervention of the LAD, LCx, or both, an intermediate LMCA stenosis
was created with a deﬂated balloon catheter. FFR was measured in the LAD and LCx coronary arteries before
and after creation of downstream stenosis by inﬂating an angioplasty balloon within the newly placed stent.
The true FFR (FFRtrue) of the LMCA, measured in the nondiseased downstream vessel in the absence of
stenosis in the other vessel, was compared with the apparent FFR (FFRapp) measured in the presence of
stenosis.
RESULTS In 25 patients, 91 pairs of measurements were made, 71 with LAD stenosis and 20 with LCx stenosis. FFRtrue
of the LMCA was signiﬁcantly lower than FFRapp (0.81  0.08 vs. 0.83  0.08, p < 0.001), although the numerical
difference was small. This difference correlated with the severity of the downstream disease (r ¼ 0.35, p < 0.001).
In all cases in which FFRapp was >0.85, FFRtrue was >0.80.
CONCLUSIONS In most cases, downstream disease does not have a clinically signiﬁcant impact on the assessment of
FFR across an intermediate LMCA stenosis with the pressure wire positioned in the nondiseased vessel. (J Am Coll Cardiol
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FIGURE 1 Experimental Layout
Cartoon of experimental layout demonstrating deﬂated
(“winged”) balloon in the left main coronary artery, variably
inﬂated balloon within the newly placed left anterior descending
coronary artery (LAD) stent, and pressure wires down the LAD
and the left circumﬂex coronary artery.
AB BR E V I A T I O N S
AND ACRONYM S
FFR = fractional ﬂow reserve
FFRapp = apparent fractional
ﬂow reserve
FFRepi = epicardial
fractional ﬂow reserve
FFRtrue = true fractional
ﬂow reserve
LAD = left anterior
descending coronary artery
LCx = left circumﬂex
coronary artery
LMCA = left main
coronary artery
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399signiﬁcance of a coronary stenosis (2,3). Results of
large, prospective, multicenter, randomized trials
have demonstrated that lesions with an ischemic FFR
beneﬁt from revascularization, whereas those with a
nonischemic FFR can be treated safely with medical
therapy alone (4–6). This has led to an increase in
the role of FFR in guiding decisions regarding
revascularization.
One of the assumed limitations of measuring FFR
to assess the signiﬁcance of LMCA disease is the
presence of a signiﬁcant stenosis in a downstream
vessel, either the left anterior descending coronary
artery (LAD) or the left circumﬂex coronary artery
(LCx). For example, in a patient with an LAD stenosis
and intermediate LMCA disease, the FFR measured
with the pressure wire in the distal LAD will be
affected by both the LAD and LMCA disease. Previous
studies have shown that positioning the pressure
sensor between the LMCA stenosis and the LAD ste-
nosis does not allow accurate measurement of the
FFR of the LMCA because the LAD stenosis distal to
the sensor can decrease ﬂow across the LMCA and
artiﬁcially decrease the hyperemic gradient of the
LMCA (7).
To address this limitation, one might consider
placing the pressure wire in the nondiseased down-
stream vessel, for example, the LCx in a patient with
intermediate LMCA disease and an LAD stenosis.
However, in theory, the ﬂow across the LMCA ste-
nosis is affected by the ﬂow down both downstream
vessels (LAD and LCx), and, therefore, the ﬂow and
hyperemic gradient across the LMCA measured with
the pressure wire in the LCx might be decreased in
the presence of signiﬁcant LAD disease, resulting in
an artiﬁcially increased FFR. Determining the degree
to which downstream disease affects the FFR
assessment of LMCA disease in humans with the
pressure wire positioned in the nondiseased down-
stream vessel was the goal of this study.
METHODS
Patients undergoing percutaneous coronary inter-
vention of either an LAD or LCx lesion, or both, were
eligible for this study if they provided informed
written consent. After percutaneous coronary inter-
vention of the epicardial vessel, a coronary pressure
wire (St. Jude Medical, Inc., St. Paul, Minnesota) was
positioned in both the LAD and the LCx. A deﬂated
balloon catheter was positioned within the stented
segment in the LAD or LCx. Over the pressure wire
positioned in the other downstream vessel, a balloon
that had been previously inﬂated and deﬂated
(i.e., “winged”) was positioned in the LMCA to createan intermediate stenosis; if necessary, the
balloon was partially inﬂated with up to 1 mm
of saline solution and contrast media. Two
patients with de novo intermediate LMCA
disease did not require the use of a winged
balloon.
FFR, deﬁned as mean distal coronary
pressure divided by mean aortic pressure,
was measured in both vessels simultaneously
during the administration of intravenous
adenosine at 140 mg/kg/min. A baseline (true)
FFR of the LMCA (FFRtrue) from the pressure
wire in the nondiseased downstream vessel
was recorded. The balloon within the stented
segment of either the LAD or the LCx was
then gradually inﬂated to create increasingly severe
downstream disease. The apparent FFR (FFRapp) of
the LMCA from the pressure wire in the nondiseased
downstream vessel was recorded simultaneously
(Figures 1 and 2). The ﬁrst septal branch was used as
the delineator between the proximal and mid-LAD,
and the ﬁrst obtuse marginal branch was used as the
delineator between the proximal and mid-LCx.
STATISTICAL ANALYSIS. Each patient had 4 to
5 measurements of FFRapp in the nondiseased
downstream vessel with variable degrees of stenosis
in the other vessel, ranging from mild to complete
FIGURE 2 Case Example of the Effect of Complete LAD Occlusion
Images of the simultaneous coronary pressure recordings during creation of variable
downstream stenosis. (Top) The coronary pressure recorded from the LAD pressure wire
before and after balloon inﬂation within a newly placed LAD stent (the green line is distal
coronary pressure, the red line is aortic pressure, and the yellow line is FFR value).
(Bottom) The coronary pressure recorded simultaneously from the LCx pressure wire
(FFRtrue and FFRapp) before and after inﬂation of the balloon in the LAD, ultimately leading
to complete occlusion (the green line is distal coronary pressure, the red line is aortic
pressure, and the yellow line is the FFR value). FFR ¼ fractional ﬂow reserve; FFRapp ¼
apparent fractional ﬂow reserve; FFRepi ¼ epicardial fractional ﬂow reserve; FFRtrue ¼ true
fractional ﬂow reserve; LAD ¼ left anterior descending coronary artery; LM ¼ left main
coronary artery.
TABLE 1 Baseline Clinical Characteristics
Variable
Age, mean, years 64.4  8.1
Male sex 23 (95.8)
Body mass index, kg/m2 28.8  4.3
Comorbidities
Diabetes 8 (33.3)
Hypertension 22 (91.7)
Dyslipidemia 23 (95.8)
Smoking 5 (20.8)
Family history of coronary disease 4 (16.7)
Downstream stenosis territory
Left anterior descending 71 (78.0)
Left circumﬂex 20 (22.0)
Downstream stenosis segment
Proximal 36 (39.6)
Mid 55 (60.4)
Values are mean  SD, or n (%).
FIGURE 3 Effect of Downstream Disease on Left Main
Coronary Artery FFR (Entire Cohort)
Comparison of FFRtrue and FFRapp of the left main coronary artery
in the entire cohort. Abbreviations as in Figure 2.
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unless otherwise stated. Paired t tests were used to
evaluate the difference between FFRtrue and FFRapp.
Paired t tests were also used to compare the differ-
ence between FFRtrue and FFRapp in different groups
including LAD versus LCx and proximal segment
versus midsegment. The intraclass correlation coef-
ﬁcient was determined using mixed-model analysis
to determine association between variables. A plot of
the difference between FFRtrue and FFRapp versus the
epicardial FFR (FFRepi) (combination of FFR of the
LMCA and the downstream disease) was used to
assess the effect of distal epicardial lesion severity on
change in LMCA FFR. We arbitrarily assigned a
change in the FFRtrue to the FFRapp of the LMCA of>0.05 to indicate a signiﬁcant change. With an SD of
0.07, we would need at least 18 paired FFR mea-
surements to have 80% power to detect a signiﬁcant
difference at a p value of 0.05. A 2-sided probability
value of 0.05 was considered signiﬁcant. Statistical
calculations were performed using SPSS version 15
(SPSS, Chicago, Illinois), and graphs were generated
using Graphpad Prism version 5.01 (Graphpad Soft-
ware, La Jolla, California).
RESULTS
A total of 25 patients were included in this study. One
patient had stenting of both the LCx and LAD and
therefore had 2 downstream stenoses created,
TABLE 2 Average Hyperemic Pressures and FFR With and
Without Downstream Stenosis
Variable
Downstream Stenosis
Mean Difference p ValueAbsent Present
Pa 89.3  16.1 89.9  18.6 0.6  7.8 0.45
Pd 72.5  15.7 74.4  19.1 1.9  7.3 0.02
FFR 0.83  0.08 0.81  0.08 0.02  0.02 <0.001
Values are mean  SD.
FFR ¼ fractional ﬂow reserve; Pa ¼ proximal or aortic pressure; Pd ¼ distal
pressure.
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evaluated in the presence of 26 downstream variable
stenoses. A total of 91 comparisons of FFRtrue with the
FFRapp were made, 71 with LAD downstream disease
and 20 with LCx downstream disease, whereas
36 were proximal and 55 were midvessel. Baseline
clinical characteristics of the patients included in this
study are shown in Table 1.
In the whole cohort, the change in FFR of the
LMCA after creation of downstream disease wasFIGURE 4 Effect of Downstream Disease on LMCA FFR
(LAD vs. LCx)
Comparison of FFRtrue and FFRapp of the LMCA with the pressure
wire in the LCx and in the presence and absence of downstream
LAD (A) and LCx (B) disease. LMCA ¼ left main coronary artery;
other abbreviations as in Figure 2.statistically signiﬁcant but numerically small, with an
absolute mean difference of 0.015 (95% conﬁdence
interval: 0.01 to 0.02) (FFRtrue vs. FFRapp was 0.81 
0.08 to 0.83  0.08, p < 0.001) (Figure 3, Table 2).
There was a signiﬁcant change in FFRtrue to FFRapp
due to downstream LAD disease (0.83  0.07 to 0.85 
0.07, p < 0.001) (Figure 4A) and a trend due to
downstream LCx disease (0.75  0.09 to 0.76  0.08,
p ¼ 0.054) (Figure 4B). FFRtrue to FFRapp also changed
signiﬁcantly when evaluating downstream disease in
the midvessel (0.82  0.08 to 0.83  0.08, p < 0.001)
and the proximal vessel (0.81  0.08 to 0.82  0.08,
p ¼ 0.002) (Figures 5A and 5B). The difference
between FFRtrue and FFRapp correlated with the
severity of the downstream disease, the composite of
the FFR of the LMCA plus the downstream stenosed
artery (epicardial FFR [FFRepi]) (mixed-model intra-
class correlation coefﬁcient r ¼ 0.93, p < 0.001). In all
cases in which the FFRapp was >0.85, the FFRtrue was
>0.80. The FFRtrue to FFRapp change was >0.05 in
only 6 cases, and the average FFRepi in these casesFIGURE 5 Effect of Downstream Disease on LMCA FFR
(Proximal vs. Midvessel)
Comparison of FFRtrue and FFRapp of the LMCA in the presence of
proximal vessel (A) and midvessel (B) downstream disease. Ab-
breviations as in Figures 2.
FIGURE 6 Bland Altman Plot Comparing FFRtrue and FFRapp
Bland-Altman plot demonstrating the relationship between
the difference in FFRtrue and FFRapp based on the severity of
downstream disease as assessed by FFR of the LMCA and the
downstream stenosis (FFRepi). Abbreviations as in Figure 2.
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average FFRepi in the cases in which the change from
FFRtrue to FFRapp was #0.05 was 0.51  0.18. A
display of the change in FFRtrue to FFRapp based on
the FFRepi is shown in the Bland-Altman plots in
Figures 6 and 7.
DISCUSSION
The main ﬁnding of this study is that downstream
epicardial disease can affect the FFR assessment ofFIGURE 7 Minimal Effect of Downstream Disease on
LMCA FFR
Chart demonstrating the average difference between the FFRtrue
and FFRapp depending on the severity of the downstream
stenosis (FFRepi). Abbreviations as in Figure 2.intermediate LMCA disease when the pressure wire is
positioned in the nondiseased epicardial vessel, but
the magnitude of this effect is small and, in most
cases, clinically irrelevant. This ﬁnding is consistent
with the many observational studies that have
demonstrated the safety of deferring revasculariza-
tion on an angiographically intermediate LMCA lesion
if the FFR is $0.75 to 0.80 (1,8–10). These studies
included patients with downstream epicardial disease
in which the FFR of the LMCA was assessed with the
pressure wire in the least diseased epicardial vessel,
and no correction was made to take into account
the impact of the epicardial disease in the other
vessel. The small differences between FFRtrue and
FFRapp in the present study explain why a non-
ischemic FFR remained predictive of excellent
outcome in the observational studies and support the
use of FFR to assess intermediate LMCA disease, even
in the presence of a diseased downstream epicardial
vessel.
The ﬁndings in this human validation study are
similar to what we found in studies using an in vitro
model and an animal model (11,12). In the in vitro
model, we found that downstream LAD disease
appeared to have a slightly greater impact on
increasing the FFRapp than did downstream LCx dis-
ease and that signiﬁcant changes between FFRtrue
and FFRapp occurred only with severe downstream
disease (11). Our animal model demonstrated these
ﬁndings, as well as the progressive impact of
increasingly severe downstream disease on the
change between FFRtrue to FFRapp (12). Similar to our
animal study, in this human validation, we did not
see a dramatic difference between the effect of
downstream LAD disease and downstream LCx dis-
ease, although the LAD did appear to have a greater
impact. Because the LAD, in general, supplies more
myocardium than the LCx, one would expect an LAD
lesion to have a greater effect on FFR of the LMCA
with the pressure wire in the LCx than vice versa. Our
animal model, like the current human study, also did
not show a dramatic difference between the effect of
a midvessel stenosis and that of a proximal vessel
stenosis, although one might expect a proximal lesion
to have a greater impact.
These ﬁndings together support the conclusion
that, although in theory, downstream epicardial dis-
ease affects the FFR assessment of the LMCA with the
pressure wire in the nondiseased vessel, in practice,
this effect is less than one might expect. In fact, in
this study, we found only 6 cases in which the FFRapp
was >0.05, higher than the FFRtrue; in these cases, the
FFRepi (composite of the FFR of the LMCA and
downstream stenosis) was on average 0.24, and in all
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stenosis was essentially occlusive.
CLINICAL IMPLICATIONS. From a clinical stand-
point, if one is interested in assessing the functional
signiﬁcance of an intermediate LMCA lesion in a pa-
tient with signiﬁcant downstream disease in 1 vessel
and ﬁnds that the FFR in the nondiseased vessel
is #0.80, then it can be assumed that the LMCA lesion
is functionally signiﬁcant. If the FFR is >0.85, it can
be assumed that the true FFR (in the theoretical
absence of the contralateral downstream disease) will
be >0.80. If the FFR is between 0.81 and 0.85 and the
FFRepi is #0.45, then it is possible that the true FFR
will be #0.80 after revascularization of the down-
stream epicardial disease.
STUDY LIMITATIONS. The variable stenoses in the
downstream vessel in this study were created artiﬁ-
cially with a balloon immediately after stenting, and
the intermediate LMCA disease was created artiﬁ-
cially in most cases with a deﬂated balloon. This
scenario may not be reﬂective of a more chronic
setting with atherosclerotic narrowings. There were
more cases with downstream LAD disease compared
with LCx disease; however, because one wouldexpect downstream LAD disease to have a greater
impact than LCx disease and because we observed a
trend in this direction, it is unlikely that inclusion of
more LCx cases would change the results. We did not
address the scenario when both downstream epicar-
dial vessels have signiﬁcant lesions. In this case,
pullback of the pressure wire in both vessels during
hyperemia can help to determine the contribution of
the LMCA disease to an abnormal FFR, and anatomic
evaluation with intravascular imaging may also prove
informative.
CONCLUSIONS
Downstream epicardial disease does affect the func-
tional assessment of intermediate LMCA disease with
the pressure wire in the nondiseased downstream
epicardial vessel, but the effect on FFR is small and
clinically irrelevant, unless the downstream disease is
severe.
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